ARCHIVES

ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?

This article is from The Cancer Letter archive.

Vol. 28 No. 41 | November 8, 2002

Download PDF Visit The Full Archive

Related Articles

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

May 27, 2005

Six Scientists Win Lasker Awards; UCLA Opens Liver Cancer Center; Foundation Honors Murphy.

September 22, 2000

Trials Approved by NCI CTEP For the Month of May

May 25, 2012

NCI Proposes Three New Grant Programs In Nutrition And Research; DRCCA Board, NCAB Approval Required

November 28, 1980

In Brief: Columbia Still In Running As Comprehensive Center In ’78; Illinois Withdraws Application

June 24, 1977

In Brief: NBCC Honors D’Amato, Leahy, Mack, Stevens; Center Development Officers Elect Leaders

May 8, 1998